MOTS-c Peptide: The Mitochondrial Messenger, Explained

What is MOTS-c?

MOTS-c is a short peptide, just 16 amino acids long, encoded in mitochondrial DNA rather than in the cell’s nucleus. The name stands for mitochondrial open reading frame of the 12S rRNA-c (Lee et al., 2015).

That origin is the whole story. Mitochondria carry their own small genome, and for decades it was thought to hold only a handful of protein-coding genes plus the RNA machinery to build them.

MOTS-c sits inside one of those RNA genes, the one for 12S ribosomal RNA. Think of a sentence hidden inside another sentence: read it one way and you get ribosomal RNA, read a short stretch another way and you get a peptide.

MOTS-c fact file

Feature	MOTS-c
Full name	Mitochondrial open reading frame of the 12S rRNA-c
Length	16 amino acids
Encoded in	Mitochondrial DNA, within the 12S rRNA gene
First described	2015, in Cell Metabolism
Main research areas	Metabolic signaling, insulin sensitivity in mice, nuclear gene regulation, muscle
Evidence base	Mouse and cell studies
Regulatory status	Not approved by the FDA for any use

A gene hidden in a gene

Mitochondria don’t read DNA quite the way the rest of the cell does. They use a slightly different genetic code, so one stretch of DNA can spell out different instructions depending on who’s reading it.

For MOTS-c, that matters a lot. Read with the mitochondrial code, its sequence runs into stop signals almost at once; read with the standard code used in the cytoplasm, it produces a working peptide (Lee et al., 2015).

So the instructions live in mitochondrial DNA, yet the peptide appears to be made outside the mitochondrion. A small detail, with a big implication: the cell’s two genomes are more tangled together than the textbook picture suggests.

It belongs to a small family called mitochondrial-derived peptides. Humanin, encoded in a different mitochondrial RNA gene, was found first, and MOTS-c showed it wasn’t a one-off (Lee et al., 2015).

How MOTS-c works: the AMPK connection

MOTS-c’s best-studied effect runs through AMPK, an enzyme that behaves like a fuel gauge. When energy runs low, AMPK switches on and pushes the cell toward burning fuel and taking up glucose.

In cell studies, MOTS-c interfered with the folate cycle. That led to a buildup of AICAR, an intermediate in purine production that also happens to activate AMPK (Lee et al., 2015).

So MOTS-c doesn’t flip the switch itself. It changes the chemistry upstream, and AICAR does the flipping.

The same paper found AMPK and a second signaling protein, Akt, more active in cultured human kidney cells exposed to MOTS-c. That’s a cell-culture readout, but it handed the mouse experiments a mechanism to test.

When a mitochondrial peptide reaches the nucleus

A 2018 study added a surprise. In cultured cells under metabolic stress, MOTS-c moved from the cytoplasm into the nucleus and changed the expression of nuclear genes (Kim et al., 2018).

That’s an unusual route for a peptide. It means a signal made from mitochondrial DNA can carry a message back to the main genome, a kind of two-way conversation between the cell’s two sets of genes.

What does MOTS-c do in research?

In mice, MOTS-c prevented insulin resistance and weight gain on a high-fat diet and reversed age-related insulin resistance in muscle (Lee et al., 2015). Most later research builds on those two findings.

Metabolism in mice

The 2015 study fed mice a high-fat diet, a standard way to push rodent metabolism toward insulin resistance. Mice given MOTS-c kept their insulin sensitivity and didn’t gain the weight the comparison mice did (Lee et al., 2015).

The researchers traced much of the effect to skeletal muscle, where glucose handling improved. Muscle takes up most glucose after a meal, which makes it the obvious tissue for a metabolic signal like this.

Running performance in mice

A 2021 study pushed the muscle story further. Mice given MOTS-c ran better on a treadmill, and the authors describe it as an exercise-induced regulator of age-dependent physical decline (Reynolds et al., 2021).

The same study profiled MOTS-c in the muscle and blood of mice at different ages. Because it circulates, some researchers call it a mitochondrial hormone (Reynolds et al., 2021).

MOTS-c findings by model

Model	What was reported	Source
Cultured cells	Folate cycle disrupted, AICAR up, AMPK activated	Lee et al., 2015
High-fat-fed mice	Insulin resistance and weight gain prevented	Lee et al., 2015
Older mice	Age-related insulin resistance in muscle reversed	Lee et al., 2015
Cells under metabolic stress	Moved into the nucleus, nuclear genes changed	Kim et al., 2018
Mice of different ages	Better treadmill performance	Reynolds et al., 2021

MOTS-c alongside NAD+ and epithalon

Longevity research often places MOTS-c next to NAD+ and epithalon, which sit in different parts of cellular aging. NAD+ is a coenzyme at the center of energy metabolism, while epithalon is a four-amino-acid peptide studied for telomerase activity in cell culture.

The NAD+ vs MOTS-c comparison explains why one is a signal and the other a coenzyme, and MOTS-c vs epithalon sets the two peptides side by side. Researchers who want the telomerase compound on its own can find epithalon peptide vials in the catalog.

Spartan also carries all three as the NAD+, epithalon and MOTS-c longevity panel for comparative work.

Questions to bring to any MOTS-c paper

A literature this young rewards a skeptical read. Four questions do most of the work.

• Which model? Cultured cells, young mice, old mice and high-fat-fed mice answer different questions, and a result in one won’t automatically carry to another.
• Under what stress? Many MOTS-c effects appear only under metabolic stress, so check that the comparison group faced the same challenge.
• Measuring what? Insulin sensitivity, body weight, gene expression and treadmill performance are four separate outcomes.
• From which lab? The founding papers share one lab network, so a result from an unconnected group counts for more.

Where the MOTS-c evidence is limited

MOTS-c has a striking origin and a clear mechanism, but its research record is young. The peptide was described in 2015, and the core findings come from cells and mice.

It’s also concentrated. The 2015 discovery paper and the 2018 nucleus study both come from Changhan Lee and colleagues, as does the 2021 treadmill study, so replication by other groups is the thing to watch.

Mouse metabolism isn’t a stand-in for anything else. These studies tell researchers where to look next. They can’t say what MOTS-c does outside a mouse.

Is MOTS-c FDA approved?

No. The FDA hasn’t approved MOTS-c for anything, and no MOTS-c drug exists. Material sold as MOTS-c is a research chemical for laboratory work.

Storing lyophilized MOTS-c

Research-grade MOTS-c ships as a freeze-dried powder. Unopened vials belong somewhere cold, dry and dark, under the conditions printed on the batch’s certificate of analysis.

Log the lot number against every experiment. If a result looks odd six months later, that number is how you trace it back to the material.

Checking a MOTS-c batch

A 16-residue peptide is easy to confirm, so there’s no reason to accept a batch on trust. Three things on the certificate settle it.

• Mass spectrometry should match the expected mass of the 16-amino-acid sequence.
• HPLC purity gives the percentage of the sample that is MOTS-c itself.
• A lot number on the certificate should match the one on the vial.

Spartan posts the MOTS-c COA for each lot, and MOTS-c 5mg research vials are on the product page.

The MOTS-c story so far

MOTS-c is a 16-amino-acid peptide hiding inside a mitochondrial RNA gene. In cells it works upstream of AMPK, in mice it protected insulin sensitivity on a high-fat diet, and under stress it travels to the nucleus.

It’s a young field built mostly by one lab network. Read the studies as a compelling mouse and cell story still waiting for broad replication.

MOTS-c questions, answered

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, within the 12S rRNA gene. It was first described in 2015 and is studied in mouse and cell models of metabolic signaling. It’s sold for laboratory research use only.

What does MOTS-c do in mice?

In cell studies, MOTS-c raised levels of AICAR, which activates the energy sensor AMPK. In mice it prevented insulin resistance and weight gain on a high-fat diet and reversed age-related insulin resistance in muscle.

Is MOTS-c a peptide or a hormone?

It’s a 16-amino-acid peptide. Some researchers call it a mitochondrial hormone because, in mice, it circulates in the blood and acts on tissues away from where it’s made.

What are mitochondrial-derived peptides?

They’re short peptides encoded in mitochondrial DNA instead of the nucleus. Humanin was the first one described, and MOTS-c followed in 2015 as the second well-studied member of the family.

What’s the difference between MOTS-c and NAD+?

MOTS-c is a peptide that acts as a signal. NAD+ is a coenzyme, not a peptide, that takes part directly in the cell’s energy chemistry. Both appear in metabolic and aging research, often side by side.

Where is MOTS-c made?

Its code sits in mitochondrial DNA, but the sequence only produces a working peptide when read with the standard genetic code of the cytoplasm. That suggests the peptide is assembled outside the mitochondrion.

Is MOTS-c FDA approved?

No. MOTS-c isn’t approved by the FDA for any use, and there’s no approved MOTS-c drug on the market. Research-grade material is sold for laboratory work only, under a lot-specific certificate of analysis.

Research use disclaimer. All content published by Spartan Peptides is for educational and research purposes only. It is not medical advice and is not a recommendation for human use. Products sold on this site are research compounds intended for laboratory and in vitro applications only.